AstraZeneca deal lifts FTSE 100 as the index rises 0.34% to 10,721.48
FTSE 100 rose 0.34% to 10,721.48 by 0925 GMT, with pharma shares up after AstraZeneca agreed a $2 billion stake in Summit Therapeutics.
, UK and European stock markets, click LIVE/ or type LIVE/ in a news window) Sept 29 (Reuters) — London's FTSE 100 rose on Tuesday, lifted by pharmaceutical stocks after AstraZeneca agreed to take a $2 billion stake in Summit Therapeutics to advance cancer research. 24%. 5%. 7% to a two-month high after it said it would invest $2 billion in Summit Therapeutics and collaborate on a series of studies testing their cancer treatments together.
3% after falling more than 1% on Monday, tracking a recovery in copper prices. com)